nucleoprotein inhibitors (Quantum)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namenucleoprotein inhibitors (Quantum)
Drug Alias Name3-mercapto-1,2,4-triazole derivatives (Quantum)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleoprotein inhibitors
TargetsNucleoprotein
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuantum Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuantum Pharmaceuticals LLC
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A